Plasmodium vivax Malaria in Duffy-Positive Patients in Rwanda.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
06 09 2023
06 09 2023
Historique:
received:
07
03
2023
accepted:
21
05
2023
pmc-release:
01
09
2024
medline:
8
9
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Plasmodium vivax is the second-most common malaria pathogen globally, but is considered very rare in the predominantly Duffy-negative sub-Saharan African population. In 259 malaria patients from highland southern Rwanda, we assessed Plasmodium species and Duffy blood group status by polymerase chain reaction (PCR). Plasmodium falciparum, P. vivax, Plasmodium malariae, and Plasmodium ovale were seen in 90.7%, 8.1%, 11.6%, and 5.0%, respectively. Plasmodium vivax occurred more frequently as a monoinfection than in combination with P. falciparum. All P. vivax-infected individuals showed heterozygous Duffy positivity, whereas this was the case for only 3.1% of patients with P. falciparum monoinfection and malaria-negative control subjects (P < 0.01). Based on PCR diagnosis, P. vivax is not rare in southern Rwanda. All episodes of P. vivax were observed in heterozygous Duffy-positive patients, whereas elsewhere in Africa, P. vivax is also reported in Duffy-negative individuals. Refined mapping of Plasmodium species is required to establish control and elimination strategies including all malaria species.
Identifiants
pubmed: 37549894
doi: 10.4269/ajtmh.23-0143
pii: tpmd230143
pmc: PMC10484245
doi:
Substances chimiques
Duffy Blood-Group System
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
621-623Références
Lancet. 2019 Jul 27;394(10195):332-343
pubmed: 31229233
PLoS Med. 2021 Oct 7;18(10):e1003799
pubmed: 34618814
Immunohematology. 2001;17(2):42-4
pubmed: 15373590
Lancet Glob Health. 2017 Nov;5(11):e1101-e1112
pubmed: 28967610
PLoS One. 2007 Mar 28;2(3):e336
pubmed: 17389925
Emerg Infect Dis. 2021 Jan;27(1):294-296
pubmed: 33350925
Malar J. 2022 Mar 18;21(1):93
pubmed: 35303892
Int J Infect Dis. 2021 Jul;108:63-71
pubmed: 33991680
Open Forum Infect Dis. 2022 Jan 19;9(3):ofac025
pubmed: 35187194
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5967-71
pubmed: 20231434
Emerg Infect Dis. 2022 Apr;28(4):852-855
pubmed: 35318931
N Engl J Med. 1976 Aug 5;295(6):302-4
pubmed: 778616
Infect Dis Ther. 2023 Jan;12(1):33-51
pubmed: 36378465
Clin Microbiol Rev. 2013 Jan;26(1):36-57
pubmed: 23297258
PLoS Med. 2011 Jan 25;8(1):e1000396
pubmed: 21311583
PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006230
pubmed: 29672516
J Infect Dis. 2020 Jan 14;221(3):428-437
pubmed: 31549156
Trans R Soc Trop Med Hyg. 2012 Jan;106(1):63-5
pubmed: 22018599
Sci Rep. 2022 Mar 7;12(1):3998
pubmed: 35256675
Mol Biochem Parasitol. 1993 Oct;61(2):315-20
pubmed: 8264734